Not applicableStudy completedNCT01232855What this trial is testingBiomarkers in Tissue Samples From Patients With Acute Promyelocytic LeukemiaWho this might be right forLeukemia Children's Oncology Group 10
Testing effectiveness (Phase 2)Ended earlyNCT00096148What this trial is testingIdarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+21 more National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)WithdrawnNCT00030355What this trial is testingHomoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003868What this trial is testingRadiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center 40
Early research (Phase 1)Study completedNCT00093743What this trial is testingLow-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi AnemiaWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+8 more Fred Hutchinson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00027924What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00070174What this trial is testingGemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyWho this might be right forLeukemia Children's Oncology Group 350
Large-scale testing (Phase 3)UnknownNCT00149162What this trial is testingTreating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2Who this might be right forLeukemia Assistance Publique - Hôpitaux de Paris 580
Not applicableNo Longer AvailableNCT00423826What this trial is testingUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Ended earlyNCT00245115What this trial is testingEx Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Early research (Phase 1)Ended earlyNCT05077423What this trial is testingTrial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAML, Childhood Y-mAbs Therapeutics 3
Testing effectiveness (Phase 2)WithdrawnNCT00002790What this trial is testingPrevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00060255What this trial is testingHigh-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsWho this might be right forBreast CancerLeukemiaLymphoma+4 more Roswell Park Cancer Institute 451
Large-scale testing (Phase 3)Study completedNCT00003883What this trial is testingItraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 578
Early research (Phase 1)Study completedNCT00093821What this trial is testingTanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsWho this might be right forChildhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more National Cancer Institute (NCI) 70
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Not applicableApproved For MarketingNCT01869803What this trial is testingGemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT01093586What this trial is testingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more Case Comprehensive Cancer Center 14
Not applicableStudy completedNCT00899015What this trial is testingAssessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070JWho this might be right forLeukemiaLymphoma National Institutes of Health Clinical Center (CC) 23
Large-scale testing (Phase 3)Study completedNCT00438958What this trial is testingSibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more The Canadian Blood and Marrow Transplant Group 230